查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1904659

生物技术创新与治疗市场预测至2032年：按产品、治疗领域、技术、应用、最终用户和地区分類的全球分析

Biotechnology Innovations & Therapeutics Market Forecasts to 2032 - Global Analysis By Product, Therapeutic Area, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，全球生物技术创新和治疗市场预计在 2025 年达到 12984 亿美元，预计到 2032 年将达到 22542 亿美元，在预测期内复合年增长率为 8.2%。

生物技术创新与治疗业务板块涵盖透过开发和应用生物系统、生物体和分子过程，创造先进的医疗解决方案、药物和治疗方法。此板块利用基因工程、分子生物学和生物资讯学，设计针对疾病的标靶治疗，改善诊断方法，并提升患者照护。包括基因治疗、个人化医疗、再生医学和生技药品在内的创新技术，旨在满足尚未满足的医疗需求。透过整合科学、技术和临床研究，我们正在改变医疗保健，并为全球提供更精准、高效和永续的治疗选择。

基因工程的进展

基因工程的进步正推动生物技术创新和治疗市场成长，其实现对基因的精准操控，进而开发标靶治疗。 CRISPR、基因编辑和合成生物学等技术使研究人员能够设计针对个别基因谱的客製化治疗方法，提高疗效并减少副作用。这些创新正在加速药物研发，并推动新型生技药品、再生医学和个人化医疗解决方案的开发，最终改变全球医疗服务和病患预后。

高昂的研发和製造成本

高昂的研发和生产成本持续限制市场发展。开发先进治疗方法、进行临床试验以及确保符合监管要求都需要大量的资金投入，这限制了中小企业的进入。生技药品、基因疗法和个人化药物通常涉及复杂的生产工艺，从而增加了整体成本。这些成本壁垒可能会延缓商业化进程，限制大规模应用，并为医疗服务提供者带来挑战，尤其是在新兴市场，进而影响整体市场成长潜力。

个人化和精准医疗

个人化和精准医疗代表着巨大的市场成长机会。透过利用患者特异性的基因、分子和临床数据，可以客製化治疗方法，从而提高疗效并最大限度地减少副作用。基因组学、生物标记和生物资讯学的创新正在推动肿瘤、罕见疾病和慢性病等领域的标靶治疗策略。对个人化医疗日益增长的需求，加上科技的进步，为生技公司拓展产品组合、改善全球病患的治疗效果提供了充满希望的途径。

可扩展性和製造障碍

规模化生产和製造壁垒对市场构成重大威胁。大规模生产复杂的生技药品、基因疗法和细胞疗法需要精密的设备、严格的品管和严苛的监管合规。产能有限会导致供不应求、治疗方法延迟和高成本。这些挑战阻碍了市场的快速扩张，并限制了某些地区的市场准入，使得企业难以充分利用对创新疗法日益增长的需求。

新冠疫情的感染疾病

新冠感染疾病对生物技术创新和治疗市场产生了重大影响，加速了研究、资金筹措和新型治疗方法的推出。疫苗研发、抗病毒药物和诊断技术的进步展现了生物技术在危机应变中的巨大潜力。同时，供应链中断、临床试验延误和资源重新分配也影响了非新冠治疗计划。疫情凸显了快速创新、与数位医疗整合以及全球合作的重要性，为生物技术公司应对未来医疗保健挑战奠定了基础。

预计在预测期内，肿瘤治疗领域将占据最大的市场份额。

由于癌症发病率不断上升以及对标靶治疗的需求日益增长，肿瘤治疗领域预计在预测期内将占据最大的市场份额。免疫疗法、基因疗法和个人化癌症治疗方案的创新正在提高患者的生存率和生活品质。先进的诊断技术和精准医疗正在推动早期检测和个人化治疗。持续的研发投入，以及人们日益增强的健康意识和医疗基础设施的不断完善，共同助力肿瘤治疗领域在全球市场确立了主导地位。

预计在预测期内，DNA定序领域将呈现最高的复合年增长率。

由于新一代定序技术的快速发展，预计在预测期内，DNA定序领域将达到最高成长率。成本降低、结果更快、准确性更高，正推动其在基因组研究和临床诊断领域的应用。定序技术能够识别基因突变和治疗标靶，从而支持精准医疗。肿瘤学和微生物组研究领域日益增长的应用，以及不断提升的检测能力，正在推动全球DNA定序市场强劲成长。

比最大的地区

由于患者群体不断增长和生物技术基础设施不断完善，亚太地区预计将在预测期内占据最大的市场份额。政府支持力度的加大、新兴生物技术中心的涌现以及与全球企业的合作，正在推动治疗和生技药品领域的创新。该地区对研究和临床试验的日益重视以及先进技术的应用，正在加速市场渗透。公众意识的提高、医疗保健服务的改善以及为降低医疗成本所做的努力，进一步巩固了亚太地区在全球市场的主导地位。

年复合成长率最高的地区

在预测期内，北美地区预计将呈现最高的复合年增长率，这主要得益于其强大的生物技术生态系统和先进的研究基础设施。众多大型生物技术公司的存在、创业投资资金筹措以及开创性的临床试验正在推动基因疗法、个人化医疗和生技药品领域的快速创新。技术进步、慢性病盛行率的上升以及对最先进治疗的早期应用将推动市场成长。北美地区的策略联盟和医疗保健投资使其成为生物技术创新和治疗领域的高成长地区。

免费客製化服务

购买此报告的客户可享有以下免费自订选项之一：

  • 公司概况
    • 最多三家新增市场参与企业进行全面分析
    • 主要企业SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户要求，对主要国家进行市场估算和预测，并计算复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 从产品系列、地域覆盖范围和策略联盟等方面对主要参与企业进行基准分析

目录

第一章执行摘要

第二章 前言

  • 摘要
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生物技术创新和治疗市场（按产品划分）

  • 生物製药
    • 单株抗体
    • 细胞和基因治疗
    • 疫苗
    • 重组蛋白
  • 生物加工设备及耗材
  • 生物资讯工具平台

6. 全球生物技术创新与治疗市场（依治疗领域划分）

  • 肿瘤学
  • 自体免疫疾病
  • 神经病学
  • 罕见疾病和遗传疾病
  • 循环系统疾病
  • 感染疾病

7. 全球生物技术创新与治疗市场（依技术划分）

  • DNA定序
  • 合成生物学
  • 重组DNA技术
  • CRISPR和基因编辑
  • 奈米生物技术
  • 干细胞技术
  • 细胞培养技术
  • 组织工程与再生医学

8. 全球生物技术创新和治疗市场（按应用划分）

  • 健康与红色生物技术
    • 基因治疗
    • 诊断
    • 个人化医疗
    • 再生医学
  • 食品和农业生物技术
    • 基因改造作物
    • 动物生物技术
  • 工业生物技术
  • 环境生物技术

9. 全球生物技术创新和治疗市场（按最终用户划分）

  • 生物製药生物技术公司
  • 学术和研究机构
  • 契约製造组织（CMO）
  • 受託研究机构（CRO）
  • 医院诊所

10. 全球生物技术创新与治疗市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 企业概况

  • Gilead Sciences
  • Novo Nordisk
  • Biogen
  • Alnylam Pharmaceuticals
  • Moderna
  • Vertex Pharmaceuticals
  • Roche
  • BioNTech
  • Johnson & Johnson
  • Siemens Healthineers
  • Pfizer
  • Amgen
  • Sanofi
  • Novartis
  • AstraZeneca
Product Code: SMRC32975

According to Stratistics MRC, the Global Biotechnology Innovations & Therapeutics Market is accounted for $1,298.4 billion in 2025 and is expected to reach $2,254.2 billion by 2032 growing at a CAGR of 8.2% during the forecast period. Biotechnology Innovations & Therapeutics encompass the development and application of biological systems, organisms, and molecular processes to create advanced medical solutions, drugs, and therapies. This field leverages genetic engineering, molecular biology, and bioinformatics to design targeted treatments for diseases, improve diagnostics, and enhance patient care. Innovations include gene therapies, personalized medicine, regenerative medicine, and biologics, aiming to address unmet medical needs. By combining science, technology, and clinical research, it transforms healthcare, offering more precise, effective, and sustainable therapeutic options worldwide.

Market Dynamics:

Driver:

Advances in Genetic Engineering

Advances in genetic engineering are driving the growth of the Biotechnology Innovations & Therapeutics market by enabling precise manipulation of genes to develop targeted therapies. Techniques such as CRISPR, gene editing, and synthetic biology allow researchers to design treatments tailored to individual genetic profiles, improving efficacy and reducing side effects. These innovations are accelerating drug discovery, enabling the creation of novel biologics, regenerative therapies, and personalized medicine solutions, ultimately transforming healthcare delivery and patient outcomes globally.

Restraint:

High R&D & Production Costs

High research, development, and production costs continue to restrain the market. Developing advanced therapies, conducting clinical trials, and ensuring regulatory compliance require significant financial investment, limiting accessibility for smaller companies. Biologics, gene therapies, and personalized medicines often involve complex manufacturing processes, adding to overall expenses. These cost barriers can delay commercialization, restrict large-scale adoption, and pose challenges for healthcare providers, particularly in emerging markets, affecting the overall market growth potential.

Opportunity:

Personalized & Precision Medicine

Personalized and precision medicine represents a significant growth opportunity in the market. By leveraging patient-specific genetic, molecular, and clinical data, therapies can be tailored to achieve higher efficacy and minimize adverse effects. Innovations in genomics, biomarkers, and bioinformatics facilitate targeted treatment strategies across oncology, rare diseases, and chronic conditions. The rising demand for individualized care, combined with technological advancements, provides a promising avenue for biotech companies to expand their portfolios and enhance global patient outcomes.

Threat:

Scalability & Manufacturing Barriers

Scalability and manufacturing barriers pose a critical threat to the market. Producing complex biologics, gene therapies, and cell-based treatments at commercial scale involves sophisticated equipment, strict quality control, and stringent regulatory compliance. Limitations in production capacity can lead to supply shortages, delayed therapy availability, and high costs. These challenges hinder rapid market expansion and restrict access in certain regions, making it difficult for companies to fully capitalize on the growing demand for innovative therapeutic solutions.

Covid-19 Impact:

The Covid-19 pandemic has significantly influenced the Biotechnology Innovations & Therapeutics market by accelerating research, funding, and adoption of novel therapies. Vaccine development, antiviral drugs, and diagnostic advancements showcased biotechnology's potential in crisis response. Simultaneously, supply chain disruptions, clinical trial delays, and resource reallocations impacted non-Covid therapeutic projects. The pandemic highlighted the importance of rapid innovation, digital health integration, and global collaboration, positioning biotech companies to address future healthcare challenges.

The oncology segment is expected to be the largest during the forecast period

The oncology segment is expected to account for the largest market share during the forecast period, due to rising cancer prevalence and the demand for targeted treatments. Innovations in immunotherapies, gene therapies, and personalized oncology solutions are improving patient survival and quality of life. Advanced diagnostics and precision medicine enable early detection and tailored therapies. Continuous investment in research, coupled with increasing awareness and healthcare infrastructure development, positions the oncology segment as a dominant force within the market globally.

The DNA sequencing segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the DNA sequencing segment is predicted to witness the highest growth rate, due to rapid advancements in next-generation sequencing technologies. Reduced costs, faster turnaround times, and improved accuracy are fueling adoption across genomics research and clinical diagnostics. Sequencing enables identification of genetic variations and therapeutic targets, supporting precision healthcare. Growing applications in oncology and microbiome research, combined with expanding laboratory capabilities, are driving robust growth in the DNA sequencing segment within the global market.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to growing patient populations, and expanding biotechnology infrastructure. Increased government support, emerging biotech hubs, and collaborations with global companies are fostering innovation in therapeutics and biologics. The region's focus on research, clinical trials, and adoption of advanced technologies enhances market penetration. Rising awareness, improving healthcare access, and affordability initiatives further strengthen the dominance of Asia Pacific in the market globally.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to robust biotechnology ecosystem and advanced research infrastructure. The presence of leading biotech companies, venture capital funding, and pioneering clinical trials fosters rapid innovation in gene therapies, personalized medicine, and biologics. Technological advancements, increasing prevalence of chronic and diseases, and early adoption of cutting-edge therapies drive market growth. North America's strategic collaborations and healthcare investments position it as a high-growth region in Biotechnology Innovations & Therapeutics.

Key players in the market

Some of the key players in Biotechnology Innovations & Therapeutics Market include Gilead Sciences, Novo Nordisk, Biogen, Alnylam Pharmaceuticals, Moderna, Vertex Pharmaceuticals, Roche, BioNTech, Johnson & Johnson, Siemens Healthineers, Pfizer, Amgen, Sanofi, Novartis and AstraZeneca.

Key Developments:

In November 2025, Siemens Healthineers introduced Syngo Carbon 2.0, an upgraded enterprise imaging platform. The launch integrates multimodal imaging data, AI-powered workflow automation, and cloud-based collaboration, designed to streamline radiology operations and improve diagnostic accuracy across global healthcare systems.

In October 2025, Siemens Healthineers expanded its collaboration with Varian and multiple oncology centers to accelerate precision therapy solutions. The joint venture integrates imaging, radiation therapy, and AI-driven planning tools, aiming to improve cancer treatment outcomes and strengthen Siemens' leadership in oncology care.

Products Covered:

  • Biopharmaceuticals
  • Bioprocess Equipment & Consumables
  • Bioinformatics Tools & Platforms

Therapeutic Areas Covered:

  • Oncology
  • Autoimmune Disorders
  • Neurology
  • Rare & Genetic Diseases
  • Cardiovascular Diseases
  • Infectious Diseases

Technologies Covered:

  • DNA Sequencing
  • Synthetic Biology
  • Recombinant DNA Technology
  • CRISPR & Gene Editing
  • Nanobiotechnology
  • Stem Cell Technology
  • Cell Culture Technology
  • Tissue Engineering & Regeneration

Applications Covered:

  • Health & Red Biotechnology
  • Food & Agriculture Biotechnology
  • Industrial Biotechnology
  • Environmental Biotechnology

End Users Covered:

  • Biopharma & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Manufacturing Organizations (CMOs)
  • Contract Research Organizations (CROs)
  • Hospitals & Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biotechnology Innovations & Therapeutics Market, By Product

  • 5.1 Introduction
  • 5.2 Biopharmaceuticals
    • 5.2.1 Monoclonal Antibodies
    • 5.2.2 Cell & Gene Therapies
    • 5.2.3 Vaccines
    • 5.2.4 Recombinant Proteins
  • 5.3 Bioprocess Equipment & Consumables
  • 5.4 Bioinformatics Tools & Platforms

6 Global Biotechnology Innovations & Therapeutics Market, By Therapeutic Area

  • 6.1 Introduction
  • 6.2 Oncology
  • 6.3 Autoimmune Disorders
  • 6.4 Neurology
  • 6.5 Rare & Genetic Diseases
  • 6.6 Cardiovascular Diseases
  • 6.7 Infectious Diseases

7 Global Biotechnology Innovations & Therapeutics Market, By Technology

  • 7.1 Introduction
  • 7.2 DNA Sequencing
  • 7.3 Synthetic Biology
  • 7.4 Recombinant DNA Technology
  • 7.5 CRISPR & Gene Editing
  • 7.6 Nanobiotechnology
  • 7.7 Stem Cell Technology
  • 7.8 Cell Culture Technology
  • 7.9 Tissue Engineering & Regeneration

8 Global Biotechnology Innovations & Therapeutics Market, By Application

  • 8.1 Introduction
  • 8.2 Health & Red Biotechnology
    • 8.2.1 Gene Therapy
    • 8.2.2 Diagnostics
    • 8.2.3 Personalized Medicine
    • 8.2.4 Regenerative Medicine
  • 8.3 Food & Agriculture Biotechnology
    • 8.3.1 GM Crops
    • 8.3.2 Animal Biotechnology
  • 8.4 Industrial Biotechnology
  • 8.5 Environmental Biotechnology

9 Global Biotechnology Innovations & Therapeutics Market, By End User

  • 9.1 Introduction
  • 9.2 Biopharma & Biotechnology Companies
  • 9.3 Academic & Research Institutes
  • 9.4 Contract Manufacturing Organizations (CMOs)
  • 9.5 Contract Research Organizations (CROs)
  • 9.6 Hospitals & Clinics

10 Global Biotechnology Innovations & Therapeutics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Gilead Sciences
  • 12.2 Novo Nordisk
  • 12.3 Biogen
  • 12.4 Alnylam Pharmaceuticals
  • 12.5 Moderna
  • 12.6 Vertex Pharmaceuticals
  • 12.7 Roche
  • 12.8 BioNTech
  • 12.9 Johnson & Johnson
  • 12.10 Siemens Healthineers
  • 12.11 Pfizer
  • 12.12 Amgen
  • 12.13 Sanofi
  • 12.14 Novartis
  • 12.15 AstraZeneca

List of Tables

  • Table 1 Global Biotechnology Innovations & Therapeutics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Biotechnology Innovations & Therapeutics Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Biotechnology Innovations & Therapeutics Market Outlook, By Biopharmaceuticals (2024-2032) ($MN)
  • Table 4 Global Biotechnology Innovations & Therapeutics Market Outlook, By Monoclonal Antibodies (2024-2032) ($MN)
  • Table 5 Global Biotechnology Innovations & Therapeutics Market Outlook, By Cell & Gene Therapies (2024-2032) ($MN)
  • Table 6 Global Biotechnology Innovations & Therapeutics Market Outlook, By Vaccines (2024-2032) ($MN)
  • Table 7 Global Biotechnology Innovations & Therapeutics Market Outlook, By Recombinant Proteins (2024-2032) ($MN)
  • Table 8 Global Biotechnology Innovations & Therapeutics Market Outlook, By Bioprocess Equipment & Consumables (2024-2032) ($MN)
  • Table 9 Global Biotechnology Innovations & Therapeutics Market Outlook, By Bioinformatics Tools & Platforms (2024-2032) ($MN)
  • Table 10 Global Biotechnology Innovations & Therapeutics Market Outlook, By Therapeutic Area (2024-2032) ($MN)
  • Table 11 Global Biotechnology Innovations & Therapeutics Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 12 Global Biotechnology Innovations & Therapeutics Market Outlook, By Autoimmune Disorders (2024-2032) ($MN)
  • Table 13 Global Biotechnology Innovations & Therapeutics Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 14 Global Biotechnology Innovations & Therapeutics Market Outlook, By Rare & Genetic Diseases (2024-2032) ($MN)
  • Table 15 Global Biotechnology Innovations & Therapeutics Market Outlook, By Cardiovascular Diseases (2024-2032) ($MN)
  • Table 16 Global Biotechnology Innovations & Therapeutics Market Outlook, By Infectious Diseases (2024-2032) ($MN)
  • Table 17 Global Biotechnology Innovations & Therapeutics Market Outlook, By Technology (2024-2032) ($MN)
  • Table 18 Global Biotechnology Innovations & Therapeutics Market Outlook, By DNA Sequencing (2024-2032) ($MN)
  • Table 19 Global Biotechnology Innovations & Therapeutics Market Outlook, By Synthetic Biology (2024-2032) ($MN)
  • Table 20 Global Biotechnology Innovations & Therapeutics Market Outlook, By Recombinant DNA Technology (2024-2032) ($MN)
  • Table 21 Global Biotechnology Innovations & Therapeutics Market Outlook, By CRISPR & Gene Editing (2024-2032) ($MN)
  • Table 22 Global Biotechnology Innovations & Therapeutics Market Outlook, By Nanobiotechnology (2024-2032) ($MN)
  • Table 23 Global Biotechnology Innovations & Therapeutics Market Outlook, By Stem Cell Technology (2024-2032) ($MN)
  • Table 24 Global Biotechnology Innovations & Therapeutics Market Outlook, By Cell Culture Technology (2024-2032) ($MN)
  • Table 25 Global Biotechnology Innovations & Therapeutics Market Outlook, By Tissue Engineering & Regeneration (2024-2032) ($MN)
  • Table 26 Global Biotechnology Innovations & Therapeutics Market Outlook, By Application (2024-2032) ($MN)
  • Table 27 Global Biotechnology Innovations & Therapeutics Market Outlook, By Health & Red Biotechnology (2024-2032) ($MN)
  • Table 28 Global Biotechnology Innovations & Therapeutics Market Outlook, By Gene Therapy (2024-2032) ($MN)
  • Table 29 Global Biotechnology Innovations & Therapeutics Market Outlook, By Diagnostics (2024-2032) ($MN)
  • Table 30 Global Biotechnology Innovations & Therapeutics Market Outlook, By Personalized Medicine (2024-2032) ($MN)
  • Table 31 Global Biotechnology Innovations & Therapeutics Market Outlook, By Regenerative Medicine (2024-2032) ($MN)
  • Table 32 Global Biotechnology Innovations & Therapeutics Market Outlook, By Food & Agriculture Biotechnology (2024-2032) ($MN)
  • Table 33 Global Biotechnology Innovations & Therapeutics Market Outlook, By GM Crops (2024-2032) ($MN)
  • Table 34 Global Biotechnology Innovations & Therapeutics Market Outlook, By Animal Biotechnology (2024-2032) ($MN)
  • Table 35 Global Biotechnology Innovations & Therapeutics Market Outlook, By Industrial Biotechnology (2024-2032) ($MN)
  • Table 36 Global Biotechnology Innovations & Therapeutics Market Outlook, By Environmental Biotechnology (2024-2032) ($MN)
  • Table 37 Global Biotechnology Innovations & Therapeutics Market Outlook, By End User (2024-2032) ($MN)
  • Table 38 Global Biotechnology Innovations & Therapeutics Market Outlook, By Biopharma & Biotechnology Companies (2024-2032) ($MN)
  • Table 39 Global Biotechnology Innovations & Therapeutics Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 40 Global Biotechnology Innovations & Therapeutics Market Outlook, By Contract Manufacturing Organizations (CMOs) (2024-2032) ($MN)
  • Table 41 Global Biotechnology Innovations & Therapeutics Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
  • Table 42 Global Biotechnology Innovations & Therapeutics Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.